Med. praxi. 2021;18(1):41-43 | DOI: 10.36290/med.2021.006

Idiopathic pulmonary fibrosis: how a general practitioner can help

MUDr. Martina Šterclová, Ph.D.
Pneumologická klinika 2. LF UK a FN Motol, Praha
Pneumologická klinika 1. LF UK a Thomayerovy nemocnice, Praha

Idiopathic pulmonary fibrosis is a fatal lung disease whose diagnosis and treatment present a number of pitfalls. Using a proactive approach, the general practitioner (GP) can significantly affect early determination of diagnosis - it is essential not to underestimate the patient's complaints and to examine those with signs and symptoms suggestive of respiratory tract disease by auscultation. The GP is involved in the comprehensive approach to the patient, being able to aid in diagnosing and managing side effects of the treatment. The GP plays a substantial role in providing palliative care and can help the patient and their loved ones cope with the serious condition.

Keywords: general practitioner, idiopathic pulmonary fibrosis, crepitus, clubbed fingers.

Published: April 6, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šterclová M. Idiopathic pulmonary fibrosis: how a general practitioner can help. Med. praxi. 2021;18(1):41-43. doi: 10.36290/med.2021.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vašáková M, Šterclová M. Idiopatická plicní fibróza (doporučený postup pro diagnózu, léčbu a sledování). Dostupné na www.pneumologie.cz/guidelines. [cit. 2020-08-10].
    2. Vega-Olivo M, Criner GJ. Idiopathic pulmonary fibrosis: A guide for nurse practitioners. Nurse Pract. 2018; 43(5): 48-54. Go to original source... Go to PubMed...
    3. Barratt SL, Creamer A, Hayton C, Chaudhuri N. Idiopathic Pulmonary Fibrosis (IPF): An Overview. J Clin Med. 2018; 7(8): 201. Go to original source... Go to PubMed...
    4. Sköld CM, Arnheim-Dahlström L, Bartley K, et al. Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015. Respir Med. 2019; 155: 72-78. Go to original source... Go to PubMed...
    5. Quinn C, Wisse A, Manns ST. Clinical course and management of idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2019; 14: 35. Go to original source...
    6. Moor CC, Mostard RLM, Grutters JC, et al. Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study. Respir Res. 2020; 21(1): 196. Go to original source... Go to PubMed...
    7. Maher TM, Strek ME. Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019; 20(1): 205. Go to original source... Go to PubMed...
    8. Tzilas V, Tzouvelekis A, Chrysikos S, et al. Diagnosis of Idiopathic Pulmonary Fibrosis Pragmatic Challenges in Clinical Practice. Front Med (Lausanne). 2017; 4: 151. Go to original source... Go to PubMed...
    9. Zou RH, Kass DJ, Gibson KF, Lindell KO. The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review. Pulm Ther. 2020; 6(1): 35-46. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.